Press Resease

Anti-counterfeit Pharmaceutical Packaging Market by Usage (Covert Features, Overt Features, Forensic Markers, Tamper Evidence, Track & Trace Technologies) and by Technology (RFID, Security Inks & Coatings, Security Printing & Graphics, Hologram, Mass Encoding and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2024

Published Date: 03-Sep-2018 Category: Packaging Report Format : PDF Pages: 110 Report Code: ZMR-3309 Status : Published

Global anti-counterfeit pharmaceutical packaging market expected to generate revenue of around USD 1800.3 million by the end of 2024, growing at a CAGR of around 12.21% between 2018 and 2024. Duplication of medical and pharmaceutical products in the modern-day world is a rising concern among developed and developing economies across the globe.

Description

The report covers forecast and analysis for the anti-counterfeit pharmaceutical packaging market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the anti-counterfeit pharmaceutical packaging market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the anti-counterfeit pharmaceutical packaging market on a global level.

In order to give the users of this report a comprehensive view of the anti-counterfeit pharmaceutical packaging market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein usage features segment and technology segment are benchmarked based on their market size, growth rate, and general attractiveness.

Global Anti-counterfeit Pharmaceutical Packaging Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view of the anti-counterfeit pharmaceutical packaging market by segmenting the market based on usage features, technology, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the historic and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. This segmentation includes demand for anti-counterfeit pharmaceutical packaging market based on all segments in all the regions and countries.

The report also includes detailed profiles of end players such as Zebra Technologies Corporation, Dennison Corporation, E.I. du Pont de Nemours and Company, AlpVision SA, Sicpa Holding SA, Applied DNA Sciences Inc., Amcor Limited, Authentix Inc., CCL Industries Inc., and Atlantic Zeiser GmbH.  
  
This report segments the global anti-counterfeit pharmaceutical packaging market as follows:

Global Anti-counterfeit Pharmaceutical Packaging Market: Usage features Segment Analysis

  • Covert Features
  • Overt Features
  • Forensic Markers
  • Tamper Evidence
  • Track & Trace Technologies
    • Serialization
    • Identification System

Global Anti-counterfeit Pharmaceutical Packaging Market: Technology Segment Analysis

  • RFID
    • Active Tags
    • Passive Tags
    • Semi-Active Tags
    • Security Inks & Coatings
    • Security Printing & Graphics
    • Hologram
  • Mass Encoding
    • Barcode Application
    • Digital Mass Serialization
    • Digital Mass Encryption
  • Others

Global Anti-counterfeit Pharmaceutical Packaging Market: Regional 

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global anti-counterfeit pharmaceutical packaging market, 2015 - 2024 (USD Million)
    • 2.2. Global anti-counterfeit pharmaceutical packaging market: snapshot
  •  
  • Chapter 3. Anti-counterfeit Pharmaceutical Packaging Market- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global anti-counterfeit pharmaceutical packaging market drivers: impact analysis
      • 3.2.2. Easy integration in of new technologies
      • 3.2.3. Rising health concerns among people
    • 3.3. Market Restraints
      • 3.3.1. Global anti-counterfeit pharmaceutical packaging market restraints: impact analysis
      • 3.3.2. High cost of implementation for infrastructure
    • 3.4. Opportunities
      • 3.4.1. Collaborative approach by companies and goverment
    • 3.5. Porter's five forces analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by usage features segment
      • 3.6.2. Market attractiveness analysis, by technology segment
      • 3.6.3. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Anti-counterfeit Pharmaceutical Packaging Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global anti-counterfeit pharmaceutical packaging market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Anti-counterfeit Pharmaceutical Packaging Market- Usage features Segment Analysis
    • 5.1. Global anti-counterfeit pharmaceutical packaging market: usage features overview
      • 5.1.1. Global anti-counterfeit pharmaceutical packaging market revenue share, by usage features, 2017 and 2024
    • 5.2. Covert Features
      • 5.2.1. Global anti-counterfeit pharmaceutical packaging market for covert features market, 2015 - 2024 (USD Million)
    • 5.3. Overt Features
      • 5.3.1. Global anti-counterfeit pharmaceutical packaging market for metals market, 2015 - 2024 (USD Million)
    • 5.4. Forensic Makers
      • 5.4.1. Global anti-counterfeit pharmaceutical packaging market for forensic makers market, 2015 - 2024 (USD Million)
    • 5.5. Tampered Evidence
      • 5.5.1. Global Anti-counterfeit Pharmaceutical Packaging market for tampered evidence market, 2015 - 2024 (USD Million)
    • 5.6. Track and Trace Technologies
      • 5.6.1. Global Anti-counterfeit Pharmaceutical Packaging market for track and trace technologies market, 2015 - 2024 (USD Million)
  •  
  • Chapter 6. Global Anti-counterfeit Pharmaceutical Packaging Market- Technology Segment Analysis
    • 6.1. Global anti-counterfeit pharmaceutical packaging market: technology overview
      • 6.1.1. Global anti-counterfeit pharmaceutical packaging market revenue share, by source type, 2017 and 2024
    • 6.2. RFID
      • 6.2.1. Global anti-counterfeit pharmaceutical packaging market for RFID market, 2015 - 2024 (USD Million)
    • 6.3. Security Ink Coatings
      • 6.3.1. Global anti-counterfeit pharmaceutical packaging market for security ink coatings market, 2015 - 2024 (USD Million)
    • 6.4. Security Printing and Graphics
      • 6.4.1. Global anti-counterfeit pharmaceutical packaging market for security printing and graphics market, 2015 - 2024 (USD Million)
    • 6.5. Holograms
      • 6.5.1. Global anti-counterfeit pharmaceutical packaging market for holograms market, 2015 - 2024 (USD Million)
    • 6.6. Mass Encoding
      • 6.6.1. Global anti-counterfeit pharmaceutical packaging market for mass encoding market, 2015 - 2024 (USD Million)
  •  
  • Chapter 7. Global Anti-counterfeit Pharmaceutical Packaging Market- Regional Segment Analysis
    • 7.1. Global anti-counterfeit pharmaceutical packaging market: regional overview
      • 7.1.1. Global anti-counterfeit pharmaceutical packaging market revenue share, by region, 2017 and 2024
    • 7.2. North America
      • 7.2.1. North America anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
      • 7.2.2. North America anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.2.3.2. U.S. anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.2.4. Canada
        • 7.2.4.1. Canada anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.2.4.2. Canada anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.2.5. Mexico
        • 7.2.5.1. Mexico anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.2.5.2. Mexico anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
      • 7.3.2. Europe anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.3.3. UK
        • 7.3.3.1. UK anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.3.3.2. UK anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.3.4. Germany
        • 7.3.4.1. Germany anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.3.4.2. Germany anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.3.5.2. France anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.3.6. Spain
        • 7.3.6.1. Spain anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.3.6.2. Spain anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.3.7. Russia
        • 7.3.7.1. Russia anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.3.7.2. Russia anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.3.8. Italy
        • 7.3.8.1. Italy anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.3.8.2. Italy anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
      • 7.4.2. Asia Pacific anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.4.3. China
        • 7.4.3.1. China anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.4.3.2. China anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.4.4. Japan
        • 7.4.4.1. Japan anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.4.4.2. Japan anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.4.5. India
        • 7.4.5.1. India anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.4.5.2. India anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.4.6. Southeast Asia
        • 7.4.6.1. Southeast Asia anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.4.6.2. Southeast Asia anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.4.7. Australia
        • 7.4.7.1. Australia anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.4.7.2. Australia anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.4.8.2. South Korea anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
      • 7.5.2. Latin America anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.5.3.2. Brazil anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
    • 7.6. Middle East and Africa
      • 7.6.1. Middle East and Africa anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
      • 7.6.2. Middle East and Africa anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.6.3. GCC Countries
        • 7.6.3.1. GCC Countries anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.6.3.2. GCC Countries anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
      • 7.6.4. South Africa
        • 7.6.4.1. South Africa anti-counterfeit pharmaceutical packaging market revenue, by usage features, 2015 - 2024 (USD Million)
        • 7.6.4.2. South Africa anti-counterfeit pharmaceutical packaging market revenue, by technology, 2015 - 2024 (USD Million)
  •  
  • Chapter 8. Company Profile
    • 8.1. Zebra Technologies Corporation
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Dennison Corporation
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. E.I. du Pont de Nemours and Company
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. AlpVision SA
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Sicpa Holding SA
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Applied DNA Sciences Inc.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Amcor Limited, Authentix Inc.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. CCL Industries Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Atlantic Zeiser GmbH
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments

Methodology

Free Analysis

Counterfeits or making duplicate devices are illicit reproductions of a trademarked brand which are identical to genuine products. Those counterfeit goods contain clothing, medications and pharmaceutical products, electronics, and jewelry among others. In order to counter infringement, secure packaging is necessary. Secure and safe packaging in case of medicinal and other pharmaceutical products is one of the crucial techniques to keep these products away from counterfeiting. Anti-counterfeit packaging is the next level or method of secure packaging to the product in order to diminish infringement. In the process of anti-counterfeit packaging, secure packaging is implemented that prevents duplication and assures the safety and security of the medicinal goods. Anti-counterfeit measurements are adopted by organizations with the collaboration of government in developed as well as developing nations, in order to counterfeit not only in terms of goods and products but also in terms of revenue and brand value loyalty. 

Anti-counterfeit pharmaceutical packaging is experiencing the highest growth rate for waste streams in developed as well as developing countries. Rising health awareness among the people across the globe is the main factor that is fueling the growth of the market. Medicinal and pharmaceutical products are regarded as one of the basic needs of consumer whenever they are facing some serious health issue. According to OECD (Organization for Economic Co-operation and Development), about 10% of the pharmaceutical products are counterfeit. This imitation or duplication of medical products happens in the supply chain or distribution of any organization. For this reason, the counterfeiting of the products is very difficult to counter and regulate. In addition, duplicate medicines affect the reputation of the pharmaceutical organizations along with the patient's health. Thus, organizations across the globe are adopting various technologies in order to counter the infringement of the medicinal devices. In order to retain the brand loyalty and brand image in the minds of consumers, organizations are heavily investing in R&D activities in order to come up with the secure packaging of pharmaceutical products. Such factors are contributing towards the market growth and development during the forecast time period. 

Global Anti-counterfeit Pharmaceutical Packaging Market
 
Based on the usage, the anti-counterfeit pharmaceutical packaging market is categorized into covert features, forensic markers, overt features, tamper evidence, track & trace technologies. Trace and track technologies can be bifurcated into serialization and identification. On the basis of technology, the market is segmented into RFID, security printing and graphics, security ink coatings, mass encoding, and holograms. RFID is divided into active tags, semi-active tags, and passive tags. Mass encoding can further be segmented into barcode application, digital mass encryption, and others (electronic surveillance technologies). 
 
North America held noteworthy revenue share of the global anti-counterfeit pharmaceutical packaging market in 2017 and the region is expected to continue with its regional superiority over the forecast period. The growth of this regional market is attributed because of the stringent regulations formulated by the government coupled with FDA. In addition, the region is the major biologics research hub, which exports medical and pharmaceutical products across the globe. Such factors are contributing to the growth of the market in the region. The Asia Pacific is predicted to provide significant opportunities for anti-counterfeit pharmaceutical packaging. The growth of the region is anticipated due to raising awareness among the consumers and manufacturers regarding infringement. Moreover, the rising trend towards social and healthcare system in the regions is fueling the growth of the market. Such factors are expected to drive anti-counterfeit pharmaceutical packaging market growth in the Asia Pacific region over the forecast timeframe. 
 
Some of the industry players operating in the anti-counterfeit pharmaceutical packaging market include Zebra Technologies Corporation, Dennison Corporation, E.I. du Pont de Nemours and Company, AlpVision SA, Sicpa Holding SA, Applied DNA Sciences Inc., Amcor Limited, Authentix Inc., CCL Industries Inc., and Atlantic Zeiser GmbH.

}